Compare LNTH & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNTH | ESNT |
|---|---|---|
| Founded | 1956 | 2008 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.9B |
| IPO Year | 2014 | 2013 |
| Metric | LNTH | ESNT |
|---|---|---|
| Price | $100.25 | $55.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $87.00 | $67.29 |
| AVG Volume (30 Days) | ★ 1.0M | 630.6K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | ★ 0.73 |
| EPS | 1.80 | ★ 1.82 |
| Revenue | $343,374,000.00 | ★ $1,260,935,000.00 |
| Revenue This Year | N/A | $1.12 |
| Revenue Next Year | $14.19 | $3.37 |
| P/E Ratio | $53.50 | ★ $30.87 |
| Revenue Growth | ★ 3.62 | 1.45 |
| 52 Week Low | $47.27 | $55.22 |
| 52 Week High | $102.66 | $67.09 |
| Indicator | LNTH | ESNT |
|---|---|---|
| Relative Strength Index (RSI) | 67.69 | 29.40 |
| Support Level | $91.65 | N/A |
| Resistance Level | $102.66 | $61.98 |
| Average True Range (ATR) | 3.42 | 1.22 |
| MACD | -0.10 | -0.62 |
| Stochastic Oscillator | 86.60 | 1.89 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.